FDA Briefing Docs Appear Positive For Abbott's Absorb, But Adverse Events Highlighted
This article was originally published in The Gray Sheet
An FDA panel meets March 15 to discuss Abbott's PMA for the firm's fully absorbable Absorb scaffold. Pre-meeting materials give a generally positive view of the device, but they highlight some elevated adverse-event rates.
Register for our free email digests: